Elevance Health, Inc.
ELV
$376.63
$13.893.83%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.47% | -2.91% | |||
| Total Other Revenue | -2.02% | 3.25% | |||
| Total Revenue | 0.87% | -1.90% | |||
| Cost of Revenue | -6.44% | -0.20% | |||
| Gross Profit | 24.68% | -7.06% | |||
| SG&A Expenses | 9.67% | 0.95% | |||
| Depreciation & Amortization | -31.71% | 1.23% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.98% | 0.06% | |||
| Operating Income | 247.39% | -56.40% | |||
| Income Before Tax | 971.63% | -84.71% | |||
| Income Tax Expenses | 264.35% | -251.14% | |||
| Earnings from Continuing Operations | 222.34% | -54.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 300.00% | -50.00% | |||
| Net Income | 222.49% | -53.99% | |||
| EBIT | 247.39% | -56.40% | |||
| EBITDA | 157.25% | -45.34% | |||
| EPS Basic | 225.42% | -53.68% | |||
| Normalized Basic EPS | 482.00% | -71.38% | |||
| EPS Diluted | 224.39% | -53.64% | |||
| Normalized Diluted EPS | 480.41% | -71.33% | |||
| Average Basic Shares Outstanding | -0.90% | -0.67% | |||
| Average Diluted Shares Outstanding | -0.63% | -0.85% | |||
| Dividend Per Share | 0.58% | 0.00% | |||
| Payout Ratio | -0.69% | 1.15% | |||